Literature DB >> 5164739

[Elimination of triamterene, an antikaliuretic, and its phenolic metabolite, 2,4,7-triamino-6-p-hydroxyphenylpteridine, in the urine of subjects with normal liver function and in subjects suffering from liver cirrhosis].

H Andrasch, T Fink, E Schmid.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5164739

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


× No keyword cloud information.
  4 in total

1.  Plasma and urinary levels of triamterene and certain metabolites after oral administration to man.

Authors:  U Gundert-Remy; D von Kenne; E Weber; H E Geissler; B Grebian; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

2.  Sulphate conjugation of p-hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.

Authors:  C Reiter; P G Werness; J Van Loon; L H Smith; R M Weinshilboum
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

3.  [Pharmacokinetics of triamterene in healthy subjects and patients with liver and kidney function disorders].

Authors:  E Mutschler; H J Gilfrich; H Knauf; W Möhrke; K D Völger
Journal:  Klin Wochenschr       Date:  1983-09-15

4.  Pharmacokinetics of triamterene after i.v. administration to man: determination of bioavailability.

Authors:  H J Gilfrich; G Kremer; W Möhrke; E Mutschler; K D Völger
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.